作者：
Cortes, Jorge [1]
;
Tamura, Kenji [2]
;
DeAngelo, Daniel J. [3]
;
de Bono, Johann [4]
;
Lorente, David [5]
;
Minden, Mark [6]
;
Uy, Geoffrey L. [7]
;
Kantarjian, Hagop [8]
;
Chen, Lisa S. [9]
;
Gandhi, Varsha [10]
;
Godin, Robert ;
Keating, Karen ;
McEachern, Kristen ;
Vishwanathan, Karthick ;
Pease, Janet Elizabeth ;
Dean, Emma
作者单位：
Washington Univ, Sch Med, Dept Med, Div Oncol, 660 S Euclid Ave, St Louis, MO 63110 USA
[1]
Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Expt Therapeut, 1901 East Rd, Houston, TX 77054
[2]
Christie NHS Fdn Trust, Clin Trials Unit, Manchester M20 4BX, Lancs, England
[3]
Natl Canc Ctr, Dept Breast Oncol & Med Oncol, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[4]
Royal Marsden, Prostate Canc Targeted Therapy Grp, Downs Rd, Sutton SM2 5PT, Surrey, England
[5]
Princess Margaret Hosp, Ontario Canc Inst, Div Stem Cell & Dev Biol, 610 Univ Ave, Toronto, ON M5G
[6]
AstraZeneca, 35 Gatehouse Dr, Waltham, MA 02451 USA
[7]
Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,Room D-2050, Boston, MA 02215 USA
[8]
Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Leukemia, 1901 East Rd, Houston, TX 77054 USA
[9]
AstraZeneca, 310 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0FZ, England
[10]
发布时间
2018-12-20
换一批
